UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000016550
Receipt number R000019209
Scientific Title Untreated IIIB/IV period with the EGFR mutation in the gene, phase II study of Gefitinib and the pemetrexed / bevacizumab combination maintenance therapy after Gefitinib and the cisplatin / pemetrexed / bevacizumab combination induction therapy for non-squamous epithelium non-small cell lung cancer of the latter recurrence
Date of disclosure of the study information 2015/02/16
Last modified on 2016/08/17 16:13:22

No. Disposal Last modified on Item of update
1 Insert 2015/02/16 14:53:05
2 Update 2016/08/17 10:17:49 UMIN ID1
3 Update 2016/08/17 16:13:23 Organization
Organization
Division name
Division name
Address
Address
TEL
Email
Last name of contact person
Last name of contact person
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
Name of person sending information
Name of person sending information
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
Name of primary person or sponsor
Institute
Institute
Department
Organization
Post marketing survey by drug manufacture etc., specified by Japanese law.
Organization1
Address1
Tel1
Email1
Institutions